Inhibition of naive class I-restricted T cells by altered peptide ligands

Immunology and Cell Biology

Volumn 77, Issue 4, 1999, Pages 318-323

  Koniaras, C ^a   Carbone, F R ^b   Heath, W R ^a   Lew, Andrew M ^a,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Antagonist; Ovalbumin

Indexed keywords

GAMMA INTERFERON; LIGAND; PEPTIDE; CYTOKINE; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; OVALBUMIN;

ANIMAL CELL; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CD8+ T LYMPHOCYTE; CHEMISTRY; CYTOTOXICITY; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; SECRETION; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; OVALBUMIN; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0033175680     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00828.x     Document Type: Review

References (33)

1. 1 Evavold BD, Sloan-Lancaster J, Allen PM. Tickling the TCR: Selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 1993; 14: 602-9.
2. 2 Evavold BD, Williams SG, Hsu BL, Buus S, Allen PM. Complete dissection of the Hb (64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J. Immunol. 1992; 148: 347-53.
3. 3 Evavold BD, Allen PM. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991; 252: 1308-10.
4. 4 Evavold BD, Sloan-Lancaster J, Hsu BL, Allen PM. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 1993; 150: 3131-40.
5. 5 Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993; 363: 156-9.
6. 6 Windhagen A, Scholz C, Hollsberg P, Fukaura H, Sette A, Hafler DA. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 1995; 2: 373-80.
7. 7 De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaeta FC, Grey HM, Sette A. Antigen analog major histocompatibility complexes act as antagonists of the T cell receptor. Cell 1992; 68: 625-34.
8. 8 Jameson SC, Carbone FR, Bevan MJ. Clone-specific T cell receptor antagonists of major histocompatibility complex class 1-restricted cytotoxic T cells. J. Exp. Med. 1993; 177: 1541-50.
9. 9 Klenerman P, Rowland-Jones S, McAdam S et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 1994; 369: 403-7.
10. 10 Bertoletti A, Sette A, Chisari FV et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369: 407-10.
11. 11 Alam SM, Travers PJ, Wung JL et al. T-cell-receptor affinity and thymocyte positive selection. Nature 1996; 381: 616-20
12. 12 Lyons DS, Lieberman SA, Hampl J et al. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 1996; 5: 53-61.
13. 13 Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 1994; 79: 913-22.
14. 14 Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 1995; 267: 515-18.
15. 15 Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54: 777-85.
16. 16 Jameson SC, Bevan MJ. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 1992; 22: 2663-7.
17. 17 Matsumura M, Fremont DH, Peterson PA, Wilson IA. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 1992; 257: 927-34.
18. 18 Fremont DH, Matsumura M, Stura EA, Peterson PA, Wilson IA. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 1992; 257: 919-27,
19. 19 Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA, Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl Acad. Sci. USA 1995; 92: 2479-83.
20. 20 Turner SJ, Jameson SC, Carbone FR. Functional mapping of the orientation for TCR recognition of an H2-Kb-restricted ovalbumin peptide suggests that the beta-chain subunit can dominate the determination of peptide side chain specificity. J. Immunol. 1997; 159: 2312-17.
21. 21 Chaturvedi P, Yu Q, Southwood S, Sette A, Singh B. Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells. Int. Immunol 1996; 8: 745-55.
22. 22 Karin N, Mitchell DJ, Brocke S, Ling N, Steinman L. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. J. Exp. Med. 1994; 180: 2227-37.
23. 23 Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 1993; 11: 403-50.
24. 24 Maraskovsky E, Chen WF, Shortman K. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J Immunol. 1989; 143: 1210-14.
25. 25 Martin R, Vallbracht A, Kreth HW. Interferon-gamma secretion by in vivo activated cytotoxic T lymphocytes from the blood and cerebrospinal fluid during mumps meningitis. J. Neuroimmunol. 1991; 33: 191-8.
26. 26 Charles T, Buzoni-Gatel D, Lepage A, Bernard F, Bout D. Toxoplasma gondii oral infection induces specific cytotoxic CDS alpha/beta+ Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J. Immunol. 1994, 153: 4596-603.
27. 27 Sheil JM, Shepherd SE, Klimo GF, Paterson Y. Identification of an autologous insulin B chain peptide as a target antigen for H-2Kb-restricted cytotoxic T lymphocytes. J. Exp. Med. 1992; 175: 545-52.
28. 28 Steward MW, Steensgaard J. Antibody Affinity: Thermodynamic Aspects and Biological Significance. Boca Raton: CRC Press, 1983.
29. 29 Franco A, Southwood S, Arrhenius T et al. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 1994; 24: 940-6.
30. 30 Katz-Levy Y, Kirshner SL, Sela M, Mozes E. Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs. Proc. Natl Acad. Sci. USA 1993; 90: 7000-4.
31. 31 Wauben MH, Boog CJ, van der Zee R, Joosten I, Schlief A, van Eden W. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: More than blocking alone. J. Exp. Med. 1992; 176: 667-77.
32. 32 Kuchroo VK, Greer JM, Kaul D et al. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 1994; 153: 3326-36.
33. 33 Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998; 394: 482-5.